Neuland Laboratories Ltd share price logo

Neuland Laboratories Ltd

NSE: NEULANDLAB

BSE: 524558

Small Cap

Pharma Sector

₹19220.00

-455.00

(-2.31%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Neuland Laboratories shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-26%

Searches for Neuland Laboratories on INDmoney have decreased by 26% over the last 30 days.

Investment activity on INDmoney

-4.76%

Investment activity in Neuland Laboratories among INDmoney users has decreased by 4.76% over the last 30 days.

Among the most traded stocks

287th

Neuland Laboratories was the 287th most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

21 days

INDmoney investors hold Neuland Laboratories shares for an average of 21 days.

Key Events for Neuland Laboratories

Last Dividend Declared

₹34.00 per share, declared on 12/05/2026

View Dividend History

Neuland Laboratories Stock Performance

as on October 19, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹19,135.00
    ₹19,940.00
    downward going graph

    0.44%

    Downside

    3.75%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹11,500.00
    ₹24,225.00
    downward going graph

    40.17%

    Downside

    26.04%

    Upside

    downward going graph

Neuland Laboratories share price movements today

Previous Close
₹19,675.00
Open
₹19,690.00
Volume
31.50K
Upper Circuit
₹23,610.00
Lower Circuit
₹15,740.00
Day's Low - High
₹19,135.00 - ₹19,940.00
52 Week Low - High
₹11,500.00 - ₹24,225.00

Neuland Laboratories Historical Returns

1 Month Return
-14.99 %
3 Month Return
+ 1.43 %
1 Year Return
+ 16.89 %
3 Year Return
+ 373.95 %
5 Year Return
+ 1115.72 %

Neuland Laboratories Fundamentals

as on October 19, 2026 at 4:01 pm IST

Market Cap

₹24,659.05 Cr

Return on Equity (ROE)

21.47

PE Ratio (TTM)

49.54

Return on capital employed (ROCE)

26.5

Industry PE ratio

50.28

Beta (LTM)

0.73

P/B Ratio

8.31

Dividend Yield

0.28

PEG Ratio

0.2

Quarterly Earnings Growth YOY

962.37

EPS (TTM)

282.16

Book Value

1452.37

Neuland Laboratories Stock Valuation

as on October 19, 2026 at 4:01 pm IST

Neuland Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (10.19x)

March 30, 2020

Today (49.54x)

October 19, 2026

Industry (50.28x)

October 19, 2026

Highest (118.16x)

September 16, 2025

LowHigh

Today’s Price to Earnings Ratio: 49.54x

Neuland Laboratories Technical Analysis

Track how Neuland Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish14
Bullish
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
-13.88
Bearish
CCI (20)
489.53
Bearish
RSI (14)
43.31
Neutral
Momentum (10)
-35
Bearish
ADI (14)
35.19
Bearish
Ultimate Oscillator (7,14,28)
18.49
Bearish

Moving Averages

Name

Value

Action

SMA (20)
19216.5
Bearish
EMA (20)
19214.94
Bearish
VWMA (20)
19209.02
Bearish
SMA (50)
19244.2
Bearish
EMA (50)
19239.54
Bearish
SMA (200)
19370.17
Bearish
EMA (200)
19361
Bearish
KAMA (200)
19264.84
Bearish
DEMA (200)
19209.26
Bearish

Neuland Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neuland Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Neuland Laboratories Ltd image
Neuland Laboratories Ltd
BUY24,659.05223.14%0.573642,022
Gennex Laboratories Ltd image
Gennex Laboratories Ltd
NA217.926.27%0.6420172
Haleos Labs Limited image
Haleos Labs Limited
NA465.0717.98%0.6917333
Syncom Formulations (India) Ltd image
Syncom Formulations (India) Ltd
NA2,012.5421.53%0.5176489
Bal Pharma Ltd image
Bal Pharma Ltd
NA145.96-1.44%0.846311
See all

Market expectation of Neuland Laboratories Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Neuland Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
392.83
385.01
439.6
310.84
398.03
328.36
292.75
514.27
439.71
776.25
641.58
Other Income
2.1
5.36
25.43
4.33
59.68
7.46
7.86
1.8
8.05
12.46
8.49
Total Income
394.93
390.37
465.03
315.18
457.72
335.82
300.61
516.07
447.76
788.71
650.07
Expenses
271.56
278.09
316.24
248.62
311.43
277.29
258.26
358.73
362.58
468.92
418.69
Operating Profit
121.27
106.92
123.36
62.22
86.6
51.07
34.49
155.54
77.13
307.33
222.89
Operating Profit Margin %
30.87%
27.77%
28.06%
20.02%
21.76%
15.55%
11.78%
30.24%
17.54%
39.59%
34.74%
Profit Before Interest, Tax and Depreciation
123.37
112.27
148.79
66.56
146.28
58.54
42.34
157.35
85.19
319.79
231.38
Interest
3.74
3.61
2.67
1.06
2.22
2.35
4.58
5.37
6.79
7.21
6.97
Depreciation
15.14
16.46
16.28
16.07
16.3
16.89
20.19
22.54
23.92
25.09
26.56
Profit Before Tax
104.49
92.2
129.84
49.43
127.76
39.3
17.57
129.44
54.48
287.49
197.85
Tax Paid
23.09
24.64
31.97
16.58
26.18
11.49
3.67
32.58
13.9
74.82
50.17
Profit After Tax
81.39
67.56
97.87
32.84
101.59
27.81
13.9
96.85
40.57
212.67
147.67
Total Net profit including share of profit / Loss from associate company
81.39
67.56
97.87
32.84
101.59
27.81
13.9
96.85
40.57
212.67
147.67
EPS
63.44
52.66
76.28
25.6
79.18
21.67
10.83
75.49
31.62
165.76
115.1
Actual EPS
63.44
52.66
76.28
25.6
79.18
21.67
10.83
75.49
31.62
165.76
115.1
Adjusted EPS
63.44
52.66
76.28
25.6
79.18
21.67
10.83
75.49
31.62
165.76
115.1
Diluted EPS
63.44
52.66
76.28
25.6
79.18
21.67
10.83
75.49
31.62
165.76
115.1

Neuland Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
527.41
666.83
762.71
936.91
951.08
1,191.2
1,558.58
1,476.84
2,022.99
Other Income
4.53
3.49
3.89
16.1
2.08
9.75
12.54
96.91
30.17
Total Income
531.94
670.32
766.6
953.01
953.15
1,200.95
1,571.12
1,573.75
2,053.15
Expenses
476.98
608.46
660.82
790.09
808.46
919.36
1,095.99
1,153.58
1,448.49
Operating Profit
50.43
58.37
101.89
146.82
142.62
271.84
462.59
323.26
574.5
Operating Profit Margin %
9.56%
8.75%
13.36%
15.67%
15%
22.82%
29.68%
21.89%
28.4%
Profit Before Interest, Tax and Depreciation
54.97
61.86
105.78
162.91
144.7
281.59
475.13
420.17
604.66
Interest
18.93
15.66
21.57
17.9
13.5
13.07
14
8.3
23.95
Depreciation
22.1
25.86
31.28
39.68
49.04
52.78
59.7
65.55
91.74
Profit Before Tax
13.94
20.34
52.93
105.33
82.16
215.74
401.43
346.32
488.97
Tax Paid
1.87
3.9
36.72
24.71
18.34
52.23
101.36
86.22
124.98
Profit After Tax
12.06
16.44
16.21
80.63
63.82
163.52
300.08
260.11
364
Total Net profit including share of profit / Loss from associate company
12.06
16.44
16.21
80.63
63.82
163.52
300.08
260.11
364
EPS
10.81
13.06
12.63
62.85
49.74
127.45
233.89
202.74
283.71
Actual EPS
10.81
13.06
12.63
62.85
49.74
127.45
233.89
202.74
283.71
Adjusted EPS
10.81
13.06
12.63
62.85
49.74
127.45
233.89
202.74
283.71
Diluted EPS
10.81
13.06
12.63
62.85
49.74
127.45
233.89
202.74
283.71

Neuland Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
44.83
38.68
11.27
69.91
57.34
189.36
60.39
237.21
261.18
317.4
346.68
Cash Flow from Investing Activities
-19.86
-42.12
-116.28
-77.23
-48.6
-84.47
-95.45
-61.09
-149.74
-298.01
-422.9
Cash Flow from Financing Activities
-23.62
-0.09
104.84
11.99
-5.48
-113.68
37.73
-135.79
-69.28
24.96
20.97
Net Cash Flow
1.35
-3.52
-0.16
4.65
3.27
-8.77
2.66
40.32
42.16
44.36
-55.26

Neuland Laboratories Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
32.8%
32.74%
32.72%
32.64%
32.68%
32.68%
32.68%
32.64%
32.63%
32.63%
32.62%
32.26%
DII
6.03%
6.54%
6.39%
6.38%
9.08%
10.97%
11.57%
13.54%
14.71%
15.84%
16.51%
16.26%
FII
22.69%
24.44%
25.72%
26.46%
23.86%
22.11%
21.69%
20.6%
20.9%
20.46%
21.08%
21.93%
Government
0.4%
0.4%
0.4%
0.4%
0.4%
0.4%
0.4%
0.4%
0%
0%
0%
0%
Public
38.08%
35.88%
34.76%
34.11%
33.98%
33.84%
33.67%
32.81%
31.76%
31.07%
29.79%
29.55%
Total Outstanding Shares
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
Total Shareholders
27,723
28,616
29,077
34,567
39,315
39,333
42,419
44,393
46,187
46,304
44,340
49,741

Mutual Funds Buying / Exiting Neuland Laboratories

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Neuland Laboratories

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

HDFC Flexi Cap Fund -Direct Plan - Growth Option

HDFC Flexi Cap Fund -Direct Plan - Growth Option

₹536.03 Cr

₹55.22 Cr (+11.49%)

0.55%

Mutual Funds Exiting Neuland Laboratories

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

ICICI Prudential Flexi Cap Fund Direct Growth

ICICI Prudential Flexi Cap Fund Direct Growth

₹283.45 Cr

₹128.45 Cr (-31.18%)

1.25%

Mahindra Manulife Small Cap Fund Direct Growth

Mahindra Manulife Small Cap Fund Direct Growth

₹117.39 Cr

₹80.60 Cr (-40.71%)

2.43%

Mahindra Manulife Multi Cap Fund Direct Plan Growth

Mahindra Manulife Multi Cap Fund Direct Plan Growth

₹183.25 Cr

₹72.38 Cr (-28.32%)

2.73%

Neuland Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Neuland Laboratories.

  • Neuland Laboratories Ltd Earnings Results

    Neuland Laboratories Ltd’s net profit jumped 962.37% since last year same period to ₹147.67Cr in the Q1 2026-2027. On a quarterly growth basis, Neuland Laboratories Ltd has generated -30.56% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Neuland Laboratories Ltd Dividends May,2026

    In the quarter ending March 2026, Neuland Laboratories Ltd has declared dividend of ₹34.00 per share on 12 May 2026 - translating a dividend yield of 0.18%.

    Read More about Dividends

Indices Featuring Neuland Laboratories Stock

Check stock indices that include Neuland Laboratories.

Nifty MidSmallcap 400

₹20,045.25

-225.40 (▲1.11%)

S&P BSE 250 SmallCap

₹6,826.87

-88.95 (▲1.29%)

BSE Healthcare

₹47,764.66

-503.33 (▲1.04%)

Nifty Small 100

₹18,935.75

-194.05 (▲1.01%)

S&P BSE 400 MidSmallCap

₹11,948.13

-135.61 (▲1.12%)

Nifty Smallcap 50

₹9,525.85

-57.40 (▲0.60%)

BSE 500

₹34,481.25

-364.80 (▲1.05%)

S&P BSE SmallCap Select

₹8,816.21

-47.10 (▲0.53%)

Nifty Smallcap 250

₹17,435.15

-202.50 (▲1.15%)

Nifty 500

₹22,041.60

-228.45 (▲1.03%)

Insights on Neuland Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 21.08% to 21.93% in Sep 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Laurus Labs Ltd has given 416.0% return, outperforming this stock by 42.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Laurus Labs Ltd has given 124.7% return, outperforming this stock by 107.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 212.67 Cr → 147.67 Cr (in ₹), with an average decrease of 30.6% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 32.62% to 32.26% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, NEULANDLAB stock has moved down by -15.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 29.79% to 29.55% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 12.66% to 12.45% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 788.71 Cr → 650.07 Cr (in ₹), with an average decrease of 17.6% per quarter

About Neuland Laboratories Ltd

Neuland Laboratories NLL, a private limited company founded in 1984, manufactures bulk drugs, such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin, which are exported to more than 35 countries. To part finance capacity expansion and diversify its product-mix, NLL made an initial public offering in 1994 for Rs 5.69 crores. The Research & Development has developed a process to manufacture Oflaxacin for Regulatory Markets, and the Pashamylaram unit received USFDA approval for Rantidine Hydrochloride Form. During the years 1992-2000 the company introduced Itraconazole, an antifungal drug, Ipratropium Bromide, an antiasthmatic drug, Mirtrazapine, an antidepressive drug, and Ramipril, a cardiovascular drug, while in 2001 it increased its capacity of Ciprofloxacin and Ranitidine with financial assistance from IDBI of Rs.65 lacs. In 2002, it commenced production of Ramipril and in 2003 of Citalopram Hydrobromide, Pirbuterol Acetate, Levofloxacin and Levetiracetam. Furthermore, Neuland Laboratories Ltd has a subsidiary in Delaware USA and in Japan (2008-2009). Neuland Laboratories NLL is thus well-positioned in the bulk drugs market and is continuously striving to expand its product mix with the help of innovation in research and development.

Revenue: ₹641.58Cr as on June 2026 (Q1 FY27)
Net Profit: ₹147.67Cr as on June 2026 (Q1 FY27)
Listing date: 17 May, 1995
Chairperson Name: D Saharsh Rao
OrganisationNeuland Laboratories Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOD Saharsh Rao
E-voting on sharesClick here to vote

FAQs

What is Neuland Laboratories share price today?

Neuland Laboratories share price today stands at ₹19220 as on at the close of the market. Neuland Laboratories share today touched a day high of ₹19940 and a low of ₹19135.

What is the 52 week high and 52 week low range for Neuland Laboratories share?

Neuland Laboratories touched a 52 week high of ₹24225 and a 52 week low of ₹11500. Neuland Laboratories share price today i.e. is closed at ₹19220, which is -20.66% down from its 52 week high and 67.13% up from its 52 week low.

What is Neuland Laboratories's market capitalisation today?

Neuland Laboratories market capitalisation is ₹24,659.05 Cr as on .

How to buy Neuland Laboratories shares?

To buy Neuland Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NEULANDLAB or Neuland Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Neuland Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Neuland Laboratories trading volume today?

Neuland Laboratories trading volume is 31.50K as on . This means that 31.50K shares of Neuland Laboratories were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Neuland Laboratories shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Neuland Laboratories have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 21 days. This reflects platform activity only and is not investment advice.